Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism STK17A inhibitors(serine/threonine kinase 17a inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H25N5O3 |
InChIKeyYCFFONJEHNSECY-UHFFFAOYSA-N |
CAS Registry2910938-59-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Preclinical | Germany | 09 Jun 2022 |